Recombinant turkey herpesvirus as well as preparation method and application thereof
By inserting a tandem epitope expression cassette into turkey herpesvirus, a recombinant turkey herpesvirus was constructed. Combined with intraembryonic and subcutaneous immunization with H9N2 inactivated vaccine, the problem of insufficient immune protection in chicks was solved, and effective challenge protection was achieved within 3 days.
Patent Information
- Application Number
- CN202511486376.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-10-17
- Publication Date
- 2026-03-10
AI Technical Summary
Existing avian influenza vaccines are difficult to induce an effective cellular immune response in chicks, and there is a lack of intraembryonic immunization vaccines to prevent H9N2 AIV infection, making chicks susceptible to avian influenza infection in the later stages of hatching. Existing combined immunization programs cannot provide complete protection within 3 days.
Recombinant turkey herpesvirus (rHVT-BNT) was constructed. By inserting a tandem epitope expression cassette into the HVT vector, multiple B cell and T cell epitopes were expressed. Combined with intraembryonic and subcutaneous immunization with H9N2 inactivated vaccine, a strong humoral and cellular immune response was elicited.
It significantly increases HI antibody and neutralizing antibody titers within 3 days, providing a clear protection against viral challenge, which is superior to existing protocols and is suitable for immune protection in chicks.